Peppies Peppies tortoise mark

A source guide

Who's who in the peptide debate

A reporter's map of the people shaping the peptide conversation - regulators, scientists, industry, and the advisory panel. Each entry lists their public role and a sourced summary of where they stand. For exact quotes, see the Quote Hub.

How to read this. Positions are summarized from public statements and linked to a source; the tags (access-leaning caution-leaning neutral / mixed) are our shorthand for reporters, not labels anyone has adopted for themselves. We list public affiliations only - no private contact information. To reach someone, go through their organization.
Who profits from the status quo where there is no legal, tested pathway for peptides Two groups profit from keeping peptides unregulated: Big Pharma, which protects its exclusivity, and the black market, which needs no legal competition. Everyone else pays the price - consumers and patients, licensed pharmacies, doctors and patients, public health, and the general public. Who profits from the status quo? When there's no legal, tested pathway, only two groups gain. Big Pharma protects its exclusivity The black market thrives on no legal supply Two rivals, one shared interest: keeping it unregulated. Who pays the price? Consumers & patients unsafe, untested product Licensed pharmacies locked out Doctors & patients no safe, legal option Public health bears the harm The general public poll result coming A legal, tested market would also benefit compounders, telehealth - and ventures like Peppies (see About).
Follow the incentives: the two groups that gain from the status quo are the two with a financial stake in keeping it. Everyone else pays. The consumer figure will be added when our national poll lands.

How each side actually makes money - in plain terms. Big Pharma - drug makers earn the most when the only legal way to get a medicine is their brand-name product at full price. When a licensed pharmacy can make a cheaper version, that cuts into their sales. They have a history of attempting to shut it down. It just played out with the weight-loss shots: as soon as the FDA said the shortage was over (early 2025), the makers of the leading weight-loss drugs sent legal threats to pharmacies and clinics, filed lawsuits, and asked the FDA to permanently ban the cheaper compounded copies (CNBC, STAT). Fewer legal options means more people paying brand-name prices. The black market - if there's no legal, tested place to buy, the only sellers left are the unregulated ones - so they keep the whole market to themselves.

The other side of the ledger - said plainly. A legal, tested market would create winners too: licensed compounding pharmacies, telehealth providers, and - yes - independent ventures like Peppies. We don't hide that. Our founder is a businessman who would benefit only from a legal, regulated market, and we say so on our About page. The distinction that matters: those winners exist only if the product is legal, tested and safe - the very thing that protects you. Our interest and your safety point the same direction.

Regulators & government officials

Scientists & physicians

Industry & advocacy

The advisory panel

Corrections & additions. This is a living guide. If a position is out of date or someone belongs on it, email ken@@peppies.com. Peppies is independent and does not sell peptides.